rugulovasine a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

rugulovasine A: from P. concavo-rugulosum Abe, P. islandicum, P. rubrum & P. biforme; RN given refers to (cis-(+-))-isomer; see also rugulovasine B, (trans-(+-))-isomer: 26909-34-2; structure in Merck Index, 9th ed, #8053 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	115153
MeSH ID	M0088413

Synonyms (12)

Synonym
26909-33-1
unii-90dee096c5
90dee096c5 ,
spiro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, (2'r,4s)-rel-
spiro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, cis-(+-)-
rugulovasine a
spiro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, cis-(+/-)-
spiro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, cis-
rugulovasine a [mi]
piro(benz(cd)indole-5(1h),2'(5'h)-furan)-5'-one, 3,4-dihydro-4'-methyl-4-(methylamino)-, (2'r,4s)-rel-
Q27271312
DTXSID20949700

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	1 (25.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	6 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
4-butyrolactone 4-Butyrolactone: One of the FURANS with a carbonyl thereby forming a cyclic lactone. It is an endogenous compound made from gamma-aminobutyrate and is the precursor of gamma-hydroxybutyrate. It is also used as a pharmacological agent and solvent.. tetrahydrofuranone : Any oxolane having an oxo- substituent at any position on the tetrahydrofuran ring.. gamma-butyrolactone : A butan-4-olide that is tetrahydrofuran substituted by an oxo group at position 2.	2.08	1	butan-4-olide	metabolite; neurotoxin
ruthenium Ruthenium: A hard, brittle, grayish-white rare earth metal with an atomic symbol Ru, atomic number 44, and atomic weight 101.07. It is used as a catalyst and hardener for PLATINUM and PALLADIUM.	2.08	1	iron group element atom; platinum group metal atom
rugulovasine b rugulovasine B: from P. concavo-rugulosum Abe, P. islandicum, P. rubrum & P. biforme; RN given refers to (trans-(+-))-isomer; see also rugulovasine A, (trans-(+-))-isomer: 26909-33-1; structure in Merck Index, 9th ed, #8053	2.69	3
1,5-dihydro-fad 1,5-dihydro-FAD: chromophore component of E coli DNA photolyase	2.11	1	flavin adenine dinucleotide	Escherichia coli metabolite; mouse metabolite
flavin-adenine dinucleotide Flavin-Adenine Dinucleotide: A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972)	2.11	1	flavin adenine dinucleotide; vitamin B2	cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; prosthetic group

chemdatabank.com